Home > Income Statement > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
Revenue

    Back to Income Statement
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for MEDICAMEN BIOTECH
Please provide your vote to see the results

MEDICAMEN BIOTECH Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹179 Cr₹141 Cr₹115 Cr₹11,271,608 Cr₹126 Cr

What is the latest Revenue of MEDICAMEN BIOTECH ?

The latest Revenue ratio of MEDICAMEN BIOTECH is ₹179 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹179 Cr
Mar2024₹141 Cr
Mar2023₹115 Cr
Mar2022₹11,271,608 Cr
Mar2021₹126 Cr

How is Revenue of MEDICAMEN BIOTECH Trending?

Years Revenue % Change
Mar2025 ₹179 Cr
27.29
Mar2024 ₹141 Cr
22.02
Mar2023 ₹115 Cr
-100.00
Mar2022 ₹11,271,608 Cr
8,980,974.92
Mar2021 ₹126 Cr -

Compare Revenue of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹440.5 Cr -6.8% 38.4% -6.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹447,476.0 Cr -0.1% -2.4% 13.8% Stock Analytics
DIVIS LABORATORIES ₹254,764.0 Cr 2.7% 12.9% 54.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,423.0 Cr 1.8% 2.5% 40.9% Stock Analytics
CIPLA ₹111,484.0 Cr 0.6% -3.8% -11.4% Stock Analytics
DR REDDYS LABORATORIES ₹101,005.0 Cr 3.3% 1.3% -7.6% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

-6.8%

38.4%

-6.4%

SENSEX

0.7%

-3.5%

-9.2%


You may also like the below Video Courses